MAS3329/8329 Course outline

 

Below is an outline of the topics covered in the course, together with references to the course text.  The references are generally the same in both editions: where they differ the principal reference is to the second edition, with the reference to the first edition in [].  Clicking on the links in each topic will provide a brief summary of each of the items in that topic.

 

 

No.

Topic

Contents

References to course text

1

Introduction to Clinical Trials

i)                    Definition of a trial

ii)                  Historical background

iii)                Empirical approach and importance of statistics

iv)                Ethical issues

 

i)                    1.1.

ii)                  1.2.1

iii)                1.2.2

iv)                1.2.3

2

Structure of a Trial

i)                    General structure

ii)                  Eligible patients

iii)                Control groups

iv)                Allocation at random

i)                    1.3

ii)                  1.3.1

iii)                1.3.2

iv)                1.3.3

3

Bias

i)                    What is bias

ii)                  Selection bias

iii)                Allocation bias

iv)                Assessment bias

v)                  Publication bias and stopping rules

i)                    2.1

ii)                  2.2.1

iii)                2.2.2

iv)                2.2.3

v)                  2.2.4 & 2.2.5

4

Sample size estimation

i)                    Why do it?

ii)                  Role of hypothesis tests

iii)                Normal variables

iv)                Binary variables

i)                    3.1

ii)                  3.2

iii)                3.3

iv)                3.4

5

Allocation

i)                    Simple randomization

ii)                  Random permuted blocks

iii)                Unequal randomization

iv)                Stratification

v)                  Minimization

i)                    4.1

ii)                  4.2

iii)                4.4  [4.3]

iv)                4.5  [4.4]

v)                  4.6  [4.5]

6

Assessment

i)                    Double and single blindness

ii)                  Placebos

i)                    5.1

ii)                  5.2

7

Analysis

i)                    Use of confidence intervals

ii)                  Uses and abuse of baselines

iii)                Analysis of covariance

i)                    6.2

ii)                  6.3

iii)                6.4

8

Crossover trials

i)                    The crossover design

ii)                  The model including period effect

iii)                Carryover effect

 

i)                    11.1 [10.1/10.2]

ii)                  11.3 [10.3]

iii)                11.4 [10.4]

 

9

Subgroups and multiple outcomes

i)                    Subgroup analyses

ii)                  Methods for comparing and selecting subgroups

iii)                Multiple outcomes and correction of P-values

 

i)                    9.1 [8.1]

ii)                  9.2/9.3 [8.2/8.3]

iii)                9.5/9.6 [8.5/8.6]

10

Protocols and protocol deviations

i)                    The trial protocol

ii)                  Protocol deviations

iii)                Intention to treat analysis

i)                    10.1 [9.1]

ii)                  10.2 [9.2]

iii)                10.3 [9.3]